Scroll Back to Top

Study number 779857

Screening Appointments Available.

Dates

Apr 21 2026-Jul 01 2026

Location

Daytona Beach, Florida

Age

18-65

Gender

Male OR Female

Smoker

Yes

Compensation

$12,049

Group

Cohort 2 OR 5

Study Details

This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. 

Daytona Beach, FL is currently recruiting Healthy Adults, ages 18-65. 

Refer a friend & receive $350 per qualified referral

Women Eligibility Criteria

  • Women can be of childbearing potential or non-childbearing potential.

Smoking Criteria

  • Smoking is allowed. 

Body Mass Index

  • Participants must have a BMI of:
    • 18-34

Screening procedures

  • Screening procedures for this study may include:
    • Vitals
    • Physical examination
    • Electrocardiogram (ECG)
    • Collection of blood samples
    • Drug and Alcohol testing  

Additional Details

Call Now to Schedule Your Screening Appointment! 
 

Cohort 2: 
Check-in: Apr 21
Check-out: Apr 22

Follow up Visits: Apr 24, 26, 29, May 2, 6, 13, 20, Jun 3, 17, Jul 1
Phone Calls: May 27, Jun 10, 24

 

OR 
 

Cohort 5: 
Check-in: Apr 30
Check-out: May 1

Follow up Visits: May 3, 5, 8, 11, 15, 22, 29 Jun 12, 26, Jul 10
Phone Calls: Jun 5, 19, Jul 3

BMI Calculator

Weight

Height

Feet Inches